The global elastomeric infusion pumps growth is driven by rising demand for home-based care, ambulatory treatment, and ...

You've probably seen an infusion pump, even though the name might make it sound like a mysterious piece of medical technology. These devices govern the flow of IV medications and fluids into patients.

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global programmable infusion pumps market and the market is poised to grow by USD 487.81 million during 2020-2024 at a CAGR of almost 8% ...

Renewed interest in hepatic arterial chemotherapy infusion pumps may be on the horizon, given promising overall survival findings in patients with advanced, unresectable cholangiocarcinoma. Dutch ...

For the third time in the last two years, Baxter has been hit with the FDA’s most serious label for a recall affecting its infusion pump systems. This time around, the Class I recall notice is linked ...

Infusion pumps are the most common connected medical devices in hospitals and "possess the lion's share" of cybersecurity risk, concluded Cynerio's January report. The Palo Alto Networks study, ...

Geographically, the infusion pumps market is segmented into North America, Europe, APAC, Latin America, and the Middle East & ...

Baxter’s infusion pumps are in the crosshairs once again after cybersecurity software developer Rapid7 discovered multiple potential vulnerabilities in the devices. The Sigma Spectrum infusion pumps ...

LONDON--(BUSINESS WIRE)--According to Technavio Research Report "Global Chemotherapy Infusion Pumps Market by product (LVPs and syringe pumps, and elastomeric pumps) and geography (North America, ...

Hospira's infusion pumps have been a recall magnet in recent years. Now, FDA is warning that two of its infusion pumps are vulnerable to hackers. FDA has issued an alert to healthcare facilities that ...

Chemotherapy is expected to be the second-fastest-growing application during the forecast period. Ambulatory Surgical Centers (ASCs) are expected to be the second-fastest-growing end-use industry ...

The US Food and Drug Administration (FDA) has received reports of serious adverse events, including patient injury and death, associated with the use of implantable infusion pumps in the magnetic ...